# Vera Therapeutics, Inc.: Form 8-K, filed Aug 5, 2025

- Company: [Vera Therapeutics, Inc.](/companies/vera.md) (CIK 1831828)
- Form: 8-K
- Filed: 2025-08-05
- Accepted by EDGAR: Aug 5, 2025, 16:56 ET
- Period: 2025-08-05
- Accession: 0001193125-25-173591
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1831828/000119312525173591/d42398d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1831828/000119312525173591/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1831828/000119312525173591/d42398d8k.htm

Filed Aug 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-173591. Last ingested by Listed: Nov 5, 2026, 17:26 ET. No prices; not investment advice.